Baseline angiography subgroup sees prasugrel benefit in TRILOGY ACS

It's not that angiography led to some unprecedented therapeutic benefit, investigators caution; rather, it signaled a group of patients who actually did better on prasugrel than clopidogrel in this otherwise negative trial.
Source: theHeart.org - Category: Cardiology Source Type: news